& Hargreaves, I
Electronic supplementary material Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made
Highland Longevity does not prescribe either product we prescribe compounded semaglutide, which is prepared by a state-licensed compounding pharmacy and is not FDA-approved
Having both treatment options on a single platform means patients can connect with a Canadian licensed provider to make the right choice based on clinical needs and personal circumstances, not just what happens to be affordable
Evaluating Weight Loss Pill Options: Considerations by Circumstance Based on clinical trial data, regulatory status, and access considerations, the following framework outlines factors patients may discuss with their healthcare providers